Stay updated on CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:07:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:45:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error, preventing access to the study record for NCT02859324 on ClinicalTrials.gov. This means the study details and related information are not viewable from this page.
    Difference
    18%
    Check dated 2026-09-21T22:08:07.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added an NIH grant/contract identifier under Other Study ID Numbers: 2016 ( U.S. NIH Grant/Contract ). Updated the page revision to v3.6.6, replacing the prior revision v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-31T08:41:13.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's content or metadata.
    Difference
    0.0%
    Check dated 2026-08-09T22:49:23.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This represents a minor update to the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-26T13:32:34.000Z thumbnail image

Stay in the know with updates to CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.